RAC 2.30% $1.49 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-80

  1. 7,028 Posts.
    lightbulb Created with Sketch. 875
    doesn’t seem to have the FDA paying attention

    Seems to have a CEO posting on HotCopper all day though….. Must be busy


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.